Silvia Reyes-Maya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Silvia Reyes-Maya has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Gayosso-Vázquez
Universidad Nacional Autónoma de México. Facultad de Medicina Veterinaria y Zootecnia. Departamento de Genética y Bioestadística. Laboratorio de Genética Molecular. Ciudad de México, México
1 shared publication - Carlos G. Gutierrez
Departamento de Reproducción, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autonoma de Mexico, Mexico City 04510, Mexico
1 shared publication Israel Muñoz-Velasco
Universidad Nacional Autónoma de México. Facultad de Ciencias. Departamento de Biología Celular. Ciudad de México, México
1 shared publicationMaría Luisa Escobar
Universidad Nacional Autónoma de México. Facultad de Ciencias. Departamento de Biología Celular. Ciudad de México, México
1 shared publicationOlga Margarita Echeverría
Universidad Nacional Autónoma de México. Facultad de Ciencias. Departamento de Biología Celular. Ciudad de México, México
1 shared publicationPablo Pintor Ríos
Universidad Nacional Autónoma de México. Facultad de Medicina Veterinaria y Zootecnia. Departamento de Genética y Bioestadística. Laboratorio de Genética Molecular. Ciudad de México, México
1 shared publication
Latest Publications
- Open Access
- 21 February 2025
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 12
DNA vaccine targeting GnRH-receptor reduces testosterone and induces testicular atrophy in mice
Reproductive control of invasive, feral, and domesticated animals is an urgent public health issue. Immunological vaccines are employed as an emerging strategy to target different components of the reproductive system, to achieve immunocastration. Successful use of immunogens against parts of the oocyte, spermatozoon, gonadotropin-releasing hormone (GnRH), and luteinizing hormone receptor (LHr) has been reported. In this work, a recombinant DNA vaccine was prepared (P2GnRHrP30) by the fusion of the first extracellular domain of the canine GnRH receptor (GNRHr) gene to the P2 and P30 tetanus toxoid epitopes. This construction was cloned in the pCI-NEO mammalian expression vector and evaluated as an immunocontraception DNA vaccine in male mice. The developed vaccine was demonstrated to be safe, and capable of reducing serum testosterone levels and causing testicular atrophy. Our work indicates that the first extracellular domain of the GnRHr gene may act as an immune target for reproductive control and potentially be used as a non-surgical sterilization procedure in mammals.
- 21 February 2025
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 12
Open AccessDNA vaccine targeting GnRH-receptor reduces testosterone and induces testicular atrophy in mice
Reproductive control of invasive, feral, and domesticated animals is an urgent public health issue. Immunological vaccines are employed as an emerging strategy to target different components of the reproductive system, to achieve immunocastration. Successful use of immunogens against parts of the oocyte, spermatozoon, gonadotropin-releasing hormone (GnRH), and luteinizing hormone receptor (LHr) has been reported. In this work, a recombinant DNA vaccine was prepared (P2GnRHrP30) by the fusion of the first extracellular domain of the canine GnRH receptor (GNRHr) gene to the P2 and P30 tetanus toxoid epitopes. This construction was cloned in the pCI-NEO mammalian expression vector and evaluated as an immunocontraception DNA vaccine in male mice. The developed vaccine was demonstrated to be safe, and capable of reducing serum testosterone levels and causing testicular atrophy. Our work indicates that the first extracellular domain of the GnRHr gene may act as an immune target for reproductive control and potentially be used as a non-surgical sterilization procedure in mammals.